IP Library Granted Patent US 9,115,184
Granted Patent B2
US 9,115,184 · App. 14/194,052 · Granted Aug 25, 2015

Light-inducible system for regulating protein stability

Inventors: Kimberly M. Bonger (Nijmegen, NL); Rishi Rakhit (Menlo Park, CA); Thomas J. Wandless (Menlo Park, CA)
Assignee: The Board of Trustees of The Leland Stanford Junior University
C07K14/001C07K7/08C07K14/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,115,184
App. No.
14/194,052
Granted
Aug 25, 2015
Kind
B2
Abstract

Disclosed herein are a light-inducible system and method for rapidly and reversibly modulating protein stability and function. This system and method employs conditionally stable protein domains that regulate the degradation of a fusion protein depending upon the presence or absence of a particular light source.

Claims (19)

1. A light-regulated conditional protein stability system, comprising:

a nucleic acid sequence encoding a fusion protein comprising a protein of interest fused in-frame to a light-regulated, stability-affecting polypeptide comprised of a light-sensitive degradation domain and a degron peptide selected from the group consisting of peptides identified as SEQ ID NO: 2, SEQ ID NO: 9 and SEQ ID NO: 10,

wherein, upon introduction of the nucleic acid sequence to a cell, the fusion protein is expressed and stability of the fusion protein is modulated by exposure of the cell to a non-toxic light.

2. The system of claim 1 , wherein the light-regulated, stability-affecting polypeptide comprises an amino acid sequence selected from the group of sequences identified by SEQ ID NOs: 3-8.

3. The system of claim 1 , wherein the cell is stably transformed with the nucleic acid.

4. The system of claim 3 , wherein the stably transformed cell is implanted in a living animal.

5. The system of claim 1 , wherein the nucleic acid sequence is in a viral vector.

6. The system of claim 5 , wherein the viral vector is a vaccinia virus.

7. The system of claim 1 , wherein the non-toxic light has a wavelength of approximately 450-470 nm.

8. A light sensitive degradation domain (DD) comprising an amino acid sequence selected from the group of sequences identified by SEQ ID NOs: 3-8.

9. A fusion protein comprising the light sensitive DD of claim 8 .

10. A cell comprising a nucleic acid encoding a fusion protein comprising a protein of interest fused in-frame to a light-regulated, stability-affecting polypeptide, wherein the light-regulated stability-affecting polypeptide is a polypeptide having 95% sequence identity to SEQ ID NO: 4, and wherein the light-regulated stability-affecting polypeptide is fused at its C-terminus to a degradation domain selected from the sequences identified as SEQ ID NO: 2 and SEQ ID NO: 9.

11. A kit of parts comprising the system of claim 1 along with instructions for use.

12. The system of claim 1 , wherein the light-regulated, stability-affecting polypeptide is selected from (i) SEQ ID NO: 3 and (ii) sequences having 95% sequence identity to SEQ ID NO: 3.

13. The system of claim 1 , wherein the light-regulated, stability-affecting polypeptide is selected from (i) SEQ ID NO: 4 and (ii) sequences having 95% sequence identity to SEQ ID NO: 4.

14. The light sensitive degradation domain of claim 8 , wherein the light sensitive degradation domain is SEQ ID NO: 3.

15. A fusion protein comprising the light sensitive degradation domain of claim 14 .

16. The system of claim 1 , wherein the light-regulated stability-affecting polypeptide is a polypeptide having 95% sequence identity to SEQ ID NO: 4 fused at its C-terminus to a degradation domain selected from the sequences identified as SEQ ID NO: 2 and SEQ ID NO: 9.

17. The system of claim 1 , wherein the light-regulated stability-affecting polypeptide is a sequence with 98% identity to a sequence selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8, the sequence fused at its C-terminus to a degradation domain selected from the sequences identified as SEQ ID NO: 2 and SEQ ID NO: 9.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2014
From: BONGER, KIMBERLY M.; RAKHIT, RISHI; WANDLESS, THOMAS J.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 032962/0352 →
CONFIRMATORY LICENSE Recorded Mar 26, 2014
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032535/0254 →
Continuity (2)
Provisional Application 61771753 · Mar 1, 2013
Related Publication 20140249295A1 · Sep 4, 2014